Immune-mediated necrotizing myopathy with pembrolizumab: a specific neuromuscular entity.

The diagnosis of IMNM does not always take into account recent criteria for the diagnosis of this pathology. This study highlights the existence of a signal, as well as the need for collaboration between oncologists and neurologists for these neurological pathologies.